Increased alpha2-adrenergic constriction of isolated arterioles in diffuse scleroderma

Arthritis Rheum. 2000 Aug;43(8):1886-90. doi: 10.1002/1529-0131(200008)43:8<1886::AID-ANR27>3.0.CO;2-S.

Abstract

Objective: Vasospasm and ischemic organ injury are important in the pathogenesis of systemic sclerosis (SSc; scleroderma). The present study was performed to determine whether SSc arterioles have an intrinsic disturbance in vasoconstrictor activity.

Methods: Skin biopsy samples were obtained from the upper arm of 11 patients with diffuse SSc (clinically uninvolved skin) and 8 age- and sex-matched control subjects. Dermal arterioles were dissected from the biopsy sample and mounted in a myograph for continuous monitoring of arteriolar diameter. The resting internal diameter of control and SSc arterioles was similar (mean +/- SEM 164+/-15 micro and 166+/-18micro, respectively).

Results: Dermal arterioles displayed no spontaneous constrictor activity in the absence of stimulation. Vasoconstriction in response to KCI, a receptor-independent activator of smooth muscle, or to phenylephrine, a selective alpha1-adrenergic receptor (alpha1-AR) agonist, was similar in control and SSc arterioles. However, constrictor responses to UK 14,304, a selective alpha2-AR agonist, were increased in SSc compared with control arterioles (maximal constriction responses of 25+/-5% and 67+/-4% [mean +/- SEM] in control and SSc arterioles, respectively; P = 0.000014). Mechanical denudation of the endothelium did not alter reactivity to alpha2-AR activation, indicating that the enhanced constriction in SSc was not mediated by changes in endothelial dilator activity. Indeed, in arterioles constricted with phenylephrine, the endothelial stimuli acetylcholine or bradykinin evoked endothelium-dependent relaxation that was similar in control and SSc arterioles.

Conclusions: Vascular smooth muscle in SSc arterioles displayed a selective increase in alpha2-AR reactivity. The endothelial dilator function appeared normal. Altered activity of smooth muscle alpha2-ARs may contribute to the vasospastic activity that is a prominent feature of the SSc disease process.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenergic alpha-2 Receptor Agonists
  • Adrenergic alpha-Agonists / pharmacology*
  • Adult
  • Arterioles / physiology*
  • Brimonidine Tartrate
  • Female
  • Humans
  • Male
  • Middle Aged
  • Phenylephrine / pharmacology
  • Quinoxalines / pharmacology*
  • Scleroderma, Systemic / physiopathology*
  • Vasoconstriction / drug effects*
  • Vasodilator Agents / pharmacology

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Adrenergic alpha-Agonists
  • Quinoxalines
  • Vasodilator Agents
  • Phenylephrine
  • Brimonidine Tartrate